ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples?serum, plasma, cell culture supernatants and cell lysates?indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling. The global average price of ELISA is in the decreasing trend, from 211 USD /Unit in 2011 to 196 USD/ Unit in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years. the classification of ELISA includes ELISA Sets ELISA Kits, and the proportion of ELISA Kits in 2015 is about 61%.ELISA is widely used in IVD testing field. USA is the largest supplier of ELISA, with a production market share nearly 48% in 2015. Europe is the second largest supplier of ELISA, enjoying production market share nearly 34% in 2015. North america is the largest consumption place, with a consumption market share nearly 40% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 26%. China is the world's largest import country. market competition is not intense. R&D Systems and Thermo Fisher Scientific, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Enzyme-Linked Immunosorbent Assay (ELISA) market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Enzyme-Linked Immunosorbent Assay (ELISA) industry. Based on our recent survey, we have several different scenarios about the Enzyme-Linked Immunosorbent Assay (ELISA) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 171.9 million in 2019. The market size of Enzyme-Linked Immunosorbent Assay (ELISA) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Enzyme-Linked Immunosorbent Assay (ELISA) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Enzyme-Linked Immunosorbent Assay (ELISA) market in terms of revenue. Players, stakeholders, and other participants in the global Enzyme-Linked Immunosorbent Assay (ELISA) market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Enzyme-Linked Immunosorbent Assay (ELISA) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Enzyme-Linked Immunosorbent Assay (ELISA) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Enzyme-Linked Immunosorbent Assay (ELISA) market. The following players are covered in this report: R&D Systems Thermo Fisher Scientific Ortho Clinical Diagnostics BD Biosciences ZEUS Scientific Bio-Rad Laboratories ALPCO Enzo Life Sciences BioM?rieux EMD Millipore BioLegend LOEWE Biochemica Shenzhen YHLO Biotech Enzyme-Linked Immunosorbent Assay (ELISA) Breakdown Data by Type ELISA Sets ELISA Kits Enzyme-Linked Immunosorbent Assay (ELISA) Breakdown Data by Application ELISA in HIV ELISA in West Nile Virus Detecting Antigens or Antibodies Biodefense
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Enzyme-Linked Immunosorbent Assay (ELISA) Revenue 1.4 Market Analysis by Type 1.4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 ELISA Sets 1.4.3 ELISA Kits 1.5 Market by Application 1.5.1 Glob
